Purchase Order 75H70723P00016
- Not listed
- Cepheid Inc. received a $756,310 firm fixed-price purchase order from the Indian Health Service (IHS) for molecular diagnostic testing supplies, specifically Cepheid 4PLEX PLUS and COVID-19 testing kits including XP3COV2/FLU/RSV-10 and XP3SARS-COV2-10 products or approved equivalents, to support clinical laboratory operations at the Zuni, New Mexico IHS facility. The contract, awarded on August 26, 2022, extends through August 31, 2027, and represents IHS's continued reliance on Cepheid's...
- The Indian Health Service (IHS) awarded Cepheid Inc. a $476,000 purchase order on July 28, 2023, for the supply of Cepheid 4Plex test kits (XP3COV2/FLU/RSV-10) to support the Albuquerque Service Unit. The contract, structured as a firm fixed-price purchase order with an ultimate completion date of July 31, 2028, represents Exercise OY-2 of a larger vehicle and does not utilize a set-aside designation. Cepheid is a Sunnyvale, California-based manufacturer specializing in molecular diagnostic...
- The Indian Health Service (IHS) awarded a $45,900 firm fixed-price purchase order to Cepheid Inc. on December 1, 2025, for molecular diagnostic solutions with a completion date of November 30, 2030. The contract, which carries no set-aside designation, will be performed in Tohatchi, New Mexico. Cepheid, a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, will deliver diagnostic testing capabilities to support IHS healthcare operations. The company...
- The Indian Health Service awarded Cepheid Inc. a firm fixed-price purchase order valued at $1.49M on February 8, 2024, for laboratory supplies and testing equipment through September 2026. The contract covers an as-needed supply of diagnostic reagents, test kits, and microbiology supplies compatible with the Cepheid GeneXpert analyzer platform, including COVID-19 testing capabilities. Performance will occur at the Indian Health Service facility in Chinle, Arizona. This award carries no small...
- The Indian Health Service (IHS) awarded a $204,000 firm fixed-price purchase order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, on December 31, 2025. The contract covers reagent testing kits for the IHS laboratory department, with an ultimate completion date of December 31, 2030. This award reflects no set-aside designation and represents a continuation of Cepheid's established relationship as a provider of molecular diagnostic...
- The Indian Health Service awarded Cepheid Inc. a delivery order valued at $10,200.00 on October 27, 2021, for Fiscal Year 2022 COVID-19 testing kits. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2021, represents a continuation of IHS's procurement of molecular diagnostic testing solutions to support tribal healthcare operations. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of...
- The Indian Health Service awarded Cepheid a $1.59M firm fixed-price purchase order on August 24, 2022, for COVID-19 test kits to support the Zuni Service Unit in New Mexico. This modification (MOD P8) updates the supply description to provide newer COVID test kits, replacing previous procurement arrangements. The contract carries no set-aside designation and will be performed in Zuni, New Mexico, with an ultimate completion date of August 31, 2027. Cepheid, a Sunnyvale, California-based...
- The Indian Health Service awarded a purchase order to Cepheid Inc. for clinical laboratory supplies with a ceiling value of $679,320 under a firm fixed-price contract. The award, announced on May 15, 2024, covers a performance period from January 1, 2024 through December 31, 2024, with an ultimate completion date of May 14, 2025. This contract modification represents a closeout action and includes no set-aside designation. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale,...
- The Indian Health Service (IHS) awarded Cepheid a Blanket Purchase Agreement (BPA) call valued at $40,000 for Cepheid test kits and supplies, with an award date of February 27, 2026 and ultimate completion date of February 28, 2027. The contract is structured as a firm fixed-price delivery order with no set-aside designation and will be performed in Winterhaven, California. Cepheid, a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, is a primary...
- The Department of Health and Human Services Indian Health Service awarded a $51,000 delivery order to Cepheid under an undisclosed contract vehicle. The firm fixed price order is for CEPHEID 4PLEX+ COVID-19 TESTING KITS XP3COV2/FLU/RSV-10, which will be delivered to a location in Crownpoint, New Mexico. Performance will take place between June 22nd and July 30th of this year. The prime contractor, Cepheid, will provide COVID-19, influenza, and respiratory syncytial virus diagnostic test kits...
The Indian Health Service (IHS) awarded Cepheid Inc. a purchase order valued at $579,168 on November 7, 2022, for Cepheid CEPHEID testing kits to support diagnostic capabilities at the Dulce, New Mexico facility. This firm fixed-price contract, with an ultimate completion date of October 31, 2027, originated from a Buy Indian pre-solicitation notice posted in June 2022 seeking Cepheid 4PLEX PLUS and COVID-19 testing kits, including the XP3COV2/FLU/RSV-10 and XP3SARS-COV2-10 products. The procurement was part of market research to determine availability and appropriate acquisition methods for molecular diagnostic testing supplies to serve tribal healthcare operations. No set-aside designation was ultimately used in the award, despite the Buy Indian evaluation criteria included in the originating opportunity. Cepheid, headquartered in Sunnyvale, California, is a primary federal supplier of advanced molecular diagnostic systems and reagents specializing in rapid infectious disease detection through its GeneXpert platform. The company has established extensive relationships across multiple federal healthcare agencies, including the Department of Veterans Affairs, Defense Health Agency, and Defense Logistics Agency, delivering diagnostic equipment, testing kits, reagents, and maintenance services. This IHS award reflects Cepheid's ongoing role in supporting clinical laboratory operations and infectious disease testing requirements across the federal healthcare system, particularly within tribal healthcare facilities in the Southwest region.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
TPSU Cepheid 4Plex and COVID-19 Testing Kits | 75H70722Q00075 | Department of Health and Human Services Indian Health Service | Solicitation 2/2 | 7/28/22, 4:02 PM | |
TPSU Cepheid 4Plex and COVID-19 Testing Kits | TPSU_Cepheid_4Plex_and_COVID-19_Testing_Kits | Department of Health and Human Services Indian Health Service | Pre-Solicitation 1/2 | 6/16/22, 12:58 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Other Administrative Action | ($72k) | 3/4/26 | |
| P00007 | Exercise an Option | $152.0k | 8/27/25 | |
| P00006 | Other Administrative Action | ($35k) | 8/19/25 | |
| P00005 | Supplemental Agreement for work within scope | $16.0k | 7/10/25 | |
| P00004 | Other Administrative Action | $0 | 5/21/25 |